Junio de 2017;42(6):1661-1675
Researchers examine how PT-141 binds to receptor subtypes and how receptor engagement influences secondary messenger pathways, gene expression markers, and neuroendocrine communication processes
PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, and MC4R that correlate with GI side effect severity and medication response intensity
While further investigations are required to fully elucidate why the phospho-null mutant GLP-1R is unable to sustain GLP-1-induced cAMP signalling in -cells, alterations in the recruitment of specific PDEs, which can potentially be cell-type specific and therefore not always replicated in non--cell systems, are likely to play an important role, as shown here by the capacity of the PDE4-specific inhibitor rolipram to restore cAMP responses from the triple AA phospho-null mutant receptor
The protocol at our Doral clinic consists of structured injection cycles followed by oral NMN maintenance weeks, allowing patients to sustain elevated NAD+ levels between injection phases